Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

This publication has 26 references indexed in Scilit:

• Ifosfamide and Etoposide Are Superior to Vincristine and Melphalan for Pediatric Metastatic Rhabdomyosarcoma When Administered With Irradiation and Combination Chemotherapy: A Report From the Intergroup Rhabdomyosarcoma Study Group
  Journal of Pediatric Hematology/Oncology, 2001
• Up-Front Window Trial of Topotecan in Previously Untreated Children and Adolescents With Metastatic Rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study
  Journal of Clinical Oncology, 2001
• A Phase II Trial of High-Dose Methotrexate in Previously Untreated Children and Adolescents with High-Risk Unresectable or Metastatic Rhabdomyosarcoma
  Journal of Pediatric Hematology/Oncology, 1997
• Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
  Bone Marrow Transplantation, 1997
• Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-an intergroup rhabdomyosarcoma study
  Cancer, 1995
• The Third Intergroup Rhabdomyosarcoma Study.
  Journal of Clinical Oncology, 1995
• The intergroup rhabdomyosarcoma study-II
  Cancer, 1993
• Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: A retrospective european multi‐center analysis
  Medical and Pediatric Oncology, 1992
• Disease patterns and survival rate in children with metastatic soft-tissue sarcoma: A report from the intergroup rhabdomyosarcoma study (IRS)-I
  Cancer, 1988
• The intergroup rhabdomyosarcoma study-I.A final report
  Cancer, 1988